News & Updates

Smartphones now have the capacity to accurately render an adult’s level of muscularity through their image capture capabilities in combination with device software applications, a recent study has shown.

Using data from the GUSTO* cohort, the DQI-5 – a Diet Quality Index developed for preschool-aged children – effectively assessed the diet quality of 5-year-olds in Singapore.

For patients with treatment-naïve advanced renal-cell carcinoma who have intermediate or poor prognostic risk, adding cabozantinib to the combination of nivolumab and ipilimumab significantly prolongs progression-free survival (PFS) compared with the combination alone but at the expense of increased grade 3 or 4 adverse events (AEs), as shown in a phase III trial.

Experimental gene therapy appears to improve eyesight in patients with a severe progressive form of Leber’s hereditary optic neuropathy (LHON) in an early access programme.

Use of selexipag shows promise in the treatment of systemic sclerosis (SSc) digital vasculopathy, according to a study.

Use of ixekizumab (IXE) for 3 years in patients with axial spondyloarthritis (axSpA) is safe, which is consistent with the previously established long-term safety profile, reports a study. Treatment with IXE results in sustained improvement of disease activity through 156 weeks.